UNSPSC 85533534: Replacement of right common iliac vein with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right common iliac vein with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06RC47Z

UNSPSC 85533534 Replacement of right common iliac vein with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that bears no meaningful relationship to recent state and local procurement activity. The code nominally describes a specific surgical procedure for vascular repair, yet the six recent state and local opportunities tagged under this code are soliciting occupational medical surveillance services, disability medical evaluation services, pharmacy benefit management, surgical center-of-excellence networks, temporary health professional staffing, and pediatric emergency medical care — none of which involve vein replacement procedures or autologous tissue grafting. The mismatch suggests either systematic misclassification within the issuing bodies' procurement systems or a fundamental disconnect between the code's medical procedure scope and how jurisdictions are actually using it in practice.

The recent opportunities span Arizona (Phoenix retirement boards), California (Long Beach, Santa Clara County), Florida (Collier County), Washington State (Department of Transportation), and Texas (Harris County), indicating geographic scatter across multiple regions and issuing-body types including municipal procurement offices, county governments, county health systems, and state departments. Without representative opportunities that genuinely align with the code's stated procedural scope, this code does not surface a viable business development path for firms offering surgical vascular services or tissue-substitute solutions to state and local buyers. Practitioners should treat this code as inactive for procurement-targeting purposes and flag the classification error to the issuing jurisdictions' procurement offices.